DAIC

SEPTEMBER 4, 2024

tim.hodson Wed, 09/04/2024 - 16:08 Sept. 1 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to act against the most debilitating disease they haven’t heard of — or know that they have.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Public Health Education 52

Medical Xpress - Cardiology

MAY 3, 2024

New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including endovascular therapy and revascularization. The data were presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.

Peripheral Arterial Disease 45

Peripheral Arterial Disease 45

Medical Xpress - Cardiology

MAY 2, 2024

New study findings underscore gaps in clinical trial representation of women and Hispanics for peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI) research. All studies were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.

Peripheral Arterial Disease 45

Peripheral Arterial Disease Ischemia Research 45

DAIC

JULY 11, 2024

a Mountain View, CA-based developer of novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), has announced the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs. Medical device company R3 Vascular Inc., Image courtesy: R3 Vascular Inc.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Stents Stent Education 105

Journal of Cardiovascular Pharmacology

MARCH 4, 2024

Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic morbidity after coronary heart disease and stroke yet is widely underdiagnosed and undertreated. Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Blood Pressure Risk Factors Nursing 40

DAIC

JUNE 4, 2024

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies 4. Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment 8.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

Circulation

APRIL 7, 2024

Circulation, Volume 149, Issue 15 , Page 1151-1153, April 9, 2024.

Peripheral Arterial Disease 45

Peripheral Arterial Disease Circulation 45

Circulation

JANUARY 24, 2024

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Stroke Strokes 81

American College of Cardiology

MAY 20, 2024

The following are key points to remember from the 2024 ACC/AHA/multisociety guideline for the management of lower extremity peripheral artery disease (PAD).

Peripheral Arterial Disease 43

Peripheral Arterial Disease Article 43

DAIC

FEBRUARY 14, 2024

The global burden of peripheral artery disease. Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. The global burden of peripheral artery disease. J Vasc Surg. 2023;77:1119-26. J Am Coll Card. 2011;57:962-70.

Heart Attack 111

Heart Attack Heart attacks Peripheral Arterial Disease Ischemia 111

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4147504-A4147504, November 12, 2024. There are discrepancies in the literature regarding whether vorapaxar alleviates ischemic outcomes and increases bleeding in patients with peripheral arterial disease (PAD).Purpose:The

Peripheral Arterial Disease 40

Peripheral Arterial Disease Ischemia Hospital Outcomes 40

American College of Cardiology

AUGUST 30, 2024

New guidance for clinicians for the evaluation and management of patients with lower extremity peripheral artery disease (LE PAD) was published in May. The 2024 ACC/AHA guideline for LE PAD, the first comprehensive update since 2016, provides evidence-based recommendations for patients across the clinical spectrum.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Article 40

The American Journal of Cardiology

AUGUST 5, 2024

Publication date: Available online 5 August 2024 Source: The American Journal of Cardiology Author(s): Sameh Sayfo, Zachary P. Rosol, David Fernandez Vazquez, Mufaddal Mamawala, Blake M. Bruneman, Sarah G. Weideman, Kennedy S. Adelman, Minseob Jeong, Bala Ramanan, Shirling Tsai, Nicolas W. Shammas, Peter P. Chu, Bertram L.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Stents Stent Outcomes 40

American College of Cardiology

JUNE 28, 2024

The Society for Cardiovascular Angiography and Interventions (SCAI) 2024 conference presented impactful research that challenged traditional practices, introduced groundbreaking technology, offered novel tools for improved procedural decision-making, addressed disparities in peripheral arterial disease (PAD) treatment, and showcased a promising new (..)

Peripheral Arterial Disease 40

Peripheral Arterial Disease Embolism Technology Pulmonary 40

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: 15 January 2024 Source: The American Journal of Cardiology, Volume 211 Author(s): Sanjot S. Sunner, Robert C. Welsh, Kevin R.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Coronary Artery Disease 52

DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:16 July 29, 2024 — CorVascular , a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) testing devices, today announced the U.S.

Certification 111

Certification Peripheral Arterial Disease Cerebrovascular Disease Quality of Life 111

American College of Cardiology

NOVEMBER 19, 2024

The 2024 multisociety Guideline for the Management of Lower Extremity Peripheral Artery Disease (PAD) recognizes the implementation of the PAD National Action Plan as a top advocacy priority.

Peripheral Arterial Disease 54

Peripheral Arterial Disease Article 54

DAIC

NOVEMBER 8, 2024

tim.hodson Fri, 11/08/2024 - 13:23 Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter that integrates two critical PAD treatments into a single device.

Innovation 52

Innovation Peripheral Arterial Disease Technology Ultrasound 52

The American Journal of Cardiology

JULY 5, 2024

Publication date: Available online 3 July 2024 Source: The American Journal of Cardiology Author(s): Asmaa Ahmed, Mohamed Hamed, Ahmed Abozaid, Ahmed Elkheshen, Mark Fisher, Wissam Khalife, Hani Jneid, Subhash Banerjee, Ayman Elbadawi

Peripheral Arterial Disease 40

Peripheral Arterial Disease 40

The American Journal of Cardiology

JUNE 12, 2024

Publication date: Available online 12 June 2024 Source: The American Journal of Cardiology Author(s): Ashish Kumar, Mariam Shariff, Monil Majmundar, John M. Stulak, Nandan Anavekar, Abhishek Deshmukh, Riyaz Bashir

Peripheral Arterial Disease 40

Peripheral Arterial Disease Ultrasound 40

The American Journal of Cardiology

APRIL 17, 2024

Publication date: Available online 16 April 2024 Source: The American Journal of Cardiology Author(s): Lawrence Hoang, Bidyut Mani, Gina Wilson, Jenifer Chisom Ogu, Subhash Banerjee, Bala Ramanan, J. Gregory Modrall, Carlos H. Timaran, Shirling Tsai

Peripheral Arterial Disease 40

Peripheral Arterial Disease 40

The American Journal of Cardiology

MAY 2, 2024

Publication date: Available online 1 May 2024 Source: The American Journal of Cardiology Author(s): Nameer Ascandar, Joseph Hadaya, Nam Yong Cho, Konmal Ali, Yas Sanaiha, Peyman Benharash

Peripheral Arterial Disease 40

Peripheral Arterial Disease Hospital Outcomes 40

Circulation

APRIL 6, 2025

Circulation, Volume 151, Issue 14 , Page e918-e918, April 8, 2025.

Peripheral Arterial Disease 45

Peripheral Arterial Disease Circulation 45

Journal of the American Heart Association

JANUARY 3, 2024

Journal of the American Heart Association, Volume 13, Issue 1 , January 2, 2024. BackgroundPeripheral artery disease (PAD) and microvascular disease (MVD) are highly prevalent conditions that share common risk factors.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Outcomes Risk Factors Hospital 40

DAIC

MARCH 20, 2024

milla1cf Wed, 03/20/2024 - 18:50 March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve below-the-knee resorbable magnesium scaffold (BTK RMS). CLTI is associated with high rates of amputation and mortality as well as high care costs.1

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

The American Journal of Cardiology

JULY 16, 2024

Publication date: Available online 15 July 2024 Source: The American Journal of Cardiology Author(s): Prakash Krishnan, Peter Faries, Khusrow Niazi, Ravish Sachar, Ash Jain, Marianne Brodmann, Martin Werner, Andrew Holden, Arthur Tarricone, Trisha Tarra, Sean Lyden

Peripheral Arterial Disease 40

Peripheral Arterial Disease 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4136687-A4136687, November 12, 2024. Background:Peripheral artery disease (PAD) is associated with high morbidity and mortality and is closely related to diabetes mellitus (DM) and atherosclerosis.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Biomarkers Angioplasty Atherosclerosis 40

The American Journal of Cardiology

APRIL 4, 2024

Publication date: Available online 3 April 2024 Source: The American Journal of Cardiology Author(s): Bijen Khagi, Tatiana Belousova, Christina M. Short, Addison Taylor, Jean Bismuth, Dipan J. Shah, Gerd Brunner

Peripheral Arterial Disease 40

Peripheral Arterial Disease 40

DAIC

JANUARY 9, 2024

The roundtable provided a unique opportunity to identify knowledge gaps and discuss how IVUS can enhance our understanding and treatment of peripheral arterial and deep venous pathology."

Peripheral Arterial Disease 105

Peripheral Arterial Disease Ultrasound Angioplasty Interventional Cardiology 105

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. Presented at EuroPCR 2024. We are grateful for their unwavering commitment and support of our mission throughout the years,” continued Sirhan. JACC 2020.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

The American Journal of Cardiology

MARCH 7, 2024

Publication date: Available online 6 March 2024 Source: The American Journal of Cardiology Author(s): Yi You, Naxin Zeng, Wengao Wu, Boyang Liu, Sheng Rong, Dong Xu

Peripheral Arterial Disease 40

Peripheral Arterial Disease Diabetes 40

American College of Cardiology

MAY 20, 2024

The new 2024 Guideline for the Management of Lower Extremity Peripheral Artery Disease, released May 14 by the ACC and the American Heart Association (AHA), offers the latest, evidence-based recommendations to guide clinicians in the diagnosis and treatment of lower extremity PAD across its four clinical presentation subsets.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Article 40

DAIC

JANUARY 18, 2024

Photo: Business Wire milla1cf Thu, 01/18/2024 - 14:05 January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for patients with below-knee peripheral arterial disease (PAD) were performed successfully using its Finesse Injectable balloon catheter platform.

Angioplasty 105

Angioplasty Peripheral Arterial Disease Kidney Disease Laboratory 105

American College of Cardiology

JUNE 3, 2024

The new 2024 Guideline on the Management of Lower Extremity Peripheral Artery Disease (PAD) released by the ACC and the American Heart Association (AHA) offers the latest, evidence-based recommendations to guide clinicians in the diagnosis and treatment of lower extremity PAD across its four clinical presentation subsets: asymptomatic disease, chronic (..)

Peripheral Arterial Disease 40

Peripheral Arterial Disease Document Ischemia Article 40

DAIC

MAY 30, 2024

Elixir Medical Corporation, a privately-held company based in Milpitas, California, develops disruptive platforms to treat coronary and peripheral artery disease. Shown here: Elixir Medical CEO Motasim Sirhan. The LithiX IVL System is not approved for sale in the U.S. Calcified coronary lesions.

Stents 105

Stents Stent Peripheral Arterial Disease Cardiovascular Disease 105

The British Journal of Cardiology

AUGUST 1, 2024

1 It is associated with an increased risk of atherosclerotic cardiovascular disease, stroke and peripheral arterial disease, independent of traditional cardiovascular risk factors.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Risk Factors Cholesterol Cardiovascular Disease 40

DAIC

SEPTEMBER 16, 2024

tim.hodson Mon, 09/16/2024 - 10:49 Sept. 16, 2024 – Shockwave Medical, Inc., launch of the Shockwave E 8 Peripheral IVL Catheter, following clearance by the U.S. part of Johnson & Johnson MedTech* has announced the full U.S. Food and Drug Administration (FDA).

Peripheral Arterial Disease 52

Peripheral Arterial Disease Quality of Life Heart Attack Heart attacks 52